가금용 백신 : 시장 점유율 분석, 산업 동향 및 통계, 성장 예측(2024-2029년)

The Poultry Vaccines Market size is estimated at USD 1.39 billion in 2024, and is expected to reach USD 1.7 billion by 2029, growing at a CAGR of 4.20% during the forecast period (2024-2029).

The growth is primarily attributed to rising demand for the poultry health coupled with the increasing poultry headcount and increasing prevalence of zoonotic diseases in poultry. Furthermore, the growing consumption of meat globally, initiatives are taken by the government, growing demand for poultry-related food products, latest technologies for manufacturing new vaccines and the increasing poultry healthcare expenditure are the factors that are fueling the growth of the global poultry vaccines market.

Poultry Vaccines Market Trends

Avian influenza is Expected to Lead the Market

Avian influenza is a viral disease which is found across all the countries in the world and occurs in birds. The severity of the disease can vary from mild to severe. Avian influenza is transmitted to human beings by direct contact. Disease outbreaks have been reported in countries, such as the United States, Asia, and Europe.

The vaccines are approved only if they pass the standards set by the World Organization for Animal Health. The vaccine for the avian influenza is given to imbibe the protection against hemagglutinin (HA) protein.

According to toWorld Health Organization, On 27 March 2020, two new outbreaks of highly pathogenic avian influenza (HPAI) A(H5N2) among birds were reported to OIE from Taiwan, China. The outbreaks occurred in two townships in Yunlin county. Among 9,578 susceptible birds identified, there were 1,819 deaths and the remaining 7,759 poultry were culled.

Furthermore, the CDC has reported that the mortality for this disease is around 90%-100%. This shows that the disease is associated with the high risk. Hence, the regulatory bodies are now accelerating the process of approval for various vaccines related to the veterinary health.

North America is expected to dominate over the Forecast Period

North America poultry vaccine is expected to have a significant share in the worldwide market over the forecast period, owing to the factors, such as the increase in consumption of poultry-derived products, growing consumer awareness regarding food safety, and increasing incidence of zoonotic diseases associated with poultry.

According to the data published by the US department of agriculture (USDA), the per capita consumption of poultry products in 2016 was 107.6 pounds and was increased to 108.6 pounds in 2017. Furthermore, there is an increase in the production of eggs and hen in the region, as per the statistics published by the UNFAO. Veterinary Vaccines in the United States is regulated by the Center for Veterinary Biologics (CVB) in the Animal and Plant Health Inspection Service (APHIS). The CVB grants establishment and product license to animal health companies, to manufacture and sell veterinary biologics.

Also, in North America advancements in vaccines development include the development of live vector vaccines, non-replicating recombinant antigen vaccines, nucleic acid-mediated vaccines, and live-gene-deleted vaccines. This is likely to fuel the market growth over forecast period.

Poultry Vaccines Industry Overview

The market players in the poultry vaccines market are involving in various growth strategies such as collaborations, partnerships, agreements, mergers and acquisitions in order to enhance the market presence. Few key players in the market are Bio-Vet, Boehringer Ingelheim, Ceva Animal Health, Elanco, Merck & Co., Phibro Animal Health Corporation, Venkys, and Zoetis Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Incidences of Poultry and Zoonotic Diseases
  • 4.2.2 Widened Focus on Food Safety
• 4.3 Market Restraints
  • 4.3.1 Use of Counterfeit Medicine
  • 4.3.2 Increasing Costs of Animal Testing and Veterinary Services
• 4.4 Porter's Five Force Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Disease
  • 5.1.1 Bronchitis
  • 5.1.2 Avian Influenza
  • 5.1.3 Newcastle disease
  • 5.1.4 Marek's Disease
  • 5.1.5 Others
• 5.2 By Technology
  • 5.2.1 Recombinant Vaccines
  • 5.2.2 Inactivated Vaccines
  • 5.2.3 Live Attenuated Vaccines (LAV)
  • 5.2.4 Others
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Biovac
  • 6.1.2 Boehringer Ingelheim International GmbH
  • 6.1.3 Ceva Sante Animale
  • 6.1.4 Dechra Pharmaceuticals PLC
  • 6.1.5 Elanco
  • 6.1.6 Hester Biosciences Limited
  • 6.1.7 Merck & Co., Inc.
  • 6.1.8 Phibro Animal Health Corporation
  • 6.1.9 Venky's Limited
  • 6.1.10 Zoetis Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS